Clinical Trial Site

Burlington, Vermont 05401

1 studies enrolling now · 2 studies all time

What they study most

Generalized Myasthenia Gravis, High Cardiovascular Risk, Hypertension

Studies at this site

• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed